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http://dx.doi.org/10Rearrangement of the mixed lineage-leukemia gene (MLL-r) is common in hematological dis-
eases and is generally associated with poor prognosis. The mixed-lineage leukemia gene trans-
located to, 3 (MLLT3) gene (9p22) is a frequent MLL-r partner (w18% of leukemias with MLL
rearrangement) and is characterized by the translocation t(9;11) (p22;q23), forming an MLL-
MLLT3 gene fusion. MLL-r are usually simple reciprocal translocations between two different
chromosomes, although karyotypes with complex MLL-r have been observed. We present a rare
case of a child with acute lymphoblastic leukemia with a complex karyotype in which the classical
t(9;11) (p22;q23) was cryptically relocated into a third chromosome in a balanced three-way
translocation. At the genome level, however, the MLL-MLLT3 three-way translocation still
displayed both reciprocal fusion transcripts. This argues in favor for a model where a simple
two-way t(9;11) (p22;q23) was likely the first step that then evolved in to a more complex
karyotype. Multicolor banding techniques can be used to greatly refine complex karyotypes
and its chromosomal breakpoints. Also in the presence of putative new rearrangements, Long
distance inverse-PCR is an important tool to identify which gene fusion is involved.
Keywords Acute lymphoblastic leukemia, MLL gene, complex karyotype, molecular
cytogenetics, long-distance inverse polymerase chain reaction
ª 2015 Elsevier Inc. All rights reserved.Rearrangements of the mixed-lineage leukemia (MLL)
gene (the Drosophila trithorax homologue) are important
and generally adverse prognostic factors in hematological
diseases (1). However, they appear to involve different
biological mechanisms, as suggested by their diversity,
their different distribution in acute lymphoblastic leukemia
(ALL) versus acute myeloid leukemia (AML) as well as inst 12, 2014; received in revised form February 7,
bruary 11, 2015.
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.1016/j.cancergen.2015.02.002infants versus children and adults, and the disparate out-
comes in these groups (2). These rearrangements are
among the most frequent genetic alterations in infant
leukemia (approximately 70% of cases), but in noninfants,
they are found in only 5e10% of AML cases and 2e5% of
ALL cases (3).
The MLLT3 gene (also known as AF9) is present in
approximately 18% of cases of acute leukemia with MLL
rearrangement (MLL-r); it is the second-most frequent of the
50-plus MLL translocation partners identified so far (4,5), but
it is not often found in cases of ALL (1). Its overall frequency
as a translocation partner in leukemia with MLL-r is approx-
imately 11.9% in ALL (infant 16.5%, pediatric 18.0%, adult
144 D.R. Ney Garcia et al.1.8%) and approximately 28.8% in AML (infant 21.9%,
pediatric 36.1%, adult 26.1%) (1). MLLT3 encodes a nuclear
protein that is part of the AF4/AF5 super elongation
complexes steering the transcriptional elongation function.
The MLL-MLLT3 fusion produces an in-frame chimeric
protein with transcriptional function that acts within a com-
plex, leading to deregulated activation of leukemic target
HOX genes (4,5).
Generally, reciprocal MLL-r variants are not cryptic. Pre-
vious investigators have suggested that the three-way MLL
variant results from a variant of a two-way-translocation (6),
which is rarely observed in complex karyotypes (1). Here we
describe a rare, complex rearrangement of the MLL-MLLT3
fusion that appears to have evolved from a simple two-way
chromosomal translocation. We investigated this case of
pediatric ALL by molecular cytogenetic techniques and long-
distance inverse (LDI)ePCR assays.Materials and methods
Case report
A 4-year-old girl with a 4-month history of a right inguinal
mass was admitted to Martag~ao Gesteira Institute of Pe-
diatrics and Child Development for clinical evaluation and
diagnosis. The patient’s medical history consisted of
weight loss and pallor. Physical examination revealed a 4-
centimeter mass in the right inguinal region but no other
enlarged lymph nodes or visceromegaly. At the time of
admission, her hemoglobin concentration was 86 g/L
(13.5e18.0 g/L); white blood cell count, 12  109 cells/L
(4  109 to 10  109 cells/L) with atypical mononuclear
cells; platelet count, 64  109/L (150  109 to 400  109
cells/L), and serum lactate dehydrogenase activity, 1291
U/L (590 U/L). Morphological evaluation of bone marrow
revealed moderate hypercellularity, with 100% of blast
cells showing lymphoid characteristics. Flow cytometry
analysis revealed a population of blast cells expressing
CD19, cIgM, cCD79a, CD22, CD20, and HLA-DR,
compatible with a pre-B-cell ALL phenotype without
CD10 expression (7).
The patient was assigned to the high risk arm of the IC-
BFM2002 ALL protocol (8). Morphologic examination of the
bone marrow on days 15 and 33 of induction chemotherapy
revealed leukemic lymphoblasts comprising more than 25%
(M3 bone marrow evaluation) and less than 5% (M1),
respectively, of mononuclear cells. Because of the results of
the M3 bone marrow evaluation at day 15, the patient un-
derwent allogeneic stem cell transplantation as directed by
the protocol. Treatment was initially well tolerated. However,
the patient died of transplant-related complications
17 months after diagnosis.Banding cytogenetics
At the time of diagnosis, standard cytogenetic G-banding
analysis was performed on bone marrow cells, and the
karyotype was described according to the International
System for Human Cytogenetic Nomenclature (ISCN
2013) (9).Molecular cytogenetics
Molecular cytogenetic studies of fluorescence in situ hybridi-
zation (FISH) were performed on metaphase spreads, using
the Cytocell Aquarius MLL dual-color, break-apart, locus-
specific probe (Oxford Gene Technology, Begbroke, UK) ac-
cording to the manufacturer’s instructions, and the karyotype
was further delineated by performing multicolor FISH (10)
using whole chromosome painting probes for chromosomes
2, 3, 9, and 11 and partial chromosome painting probes for
the 11p and 11q arms. FISH was also performed with multi-
color banding (MCB) to identify the breakpoints on chromo-
somes 3, 9, and 11. MCB was unnecessary for chromosome
2 because the breakpoint could be identified by using
G-banding, whole chromosome painting probe 2, and inverted
40, 6-diamidino-2-phenylindole (DAPI)-banding (11).
Molecular genetics
Long-distance inverse PCR (LDI-PCR) assays were per-
formed to identify the MLL transcription partner genes and
their respective breakpoints. Briefly, 1 mg of genomic DNA
was digested, and the resulting DNA fragments were self-
ligated. This re-ligated DNA was used for the subsequent
LDI-PCR analysis. PCR amplimers were purified from the gel
and subsequently sequenced to obtain chromosomal
breakpoint details (12).
Results
Cytogenetic G-banding analysis revealed an abnormal karyo-
type with a derivative chromosome 2, monosomy of chromo-
some 3, an 11q23 chromosome region that appeared to be
deleted, and a marker chromosome (Figure 1A). Partial chro-
mosome painting of the 11p and 11q arms identified chromo-
some 11p material on a chromosome 2 derivative and 11q
material on chromosome3and9derivatives (Figure1B).Results
of the FISHwith a dual-colorMLL break-apart probe showedone
normal copyof theMLLgene; the5ʹportionof theotherMLLgene
homologue appeared on the marker chromosome and its 3ʹ
portion onaderivative chromosome9 (Figure 1C).MCBanalysis
also identified the breakpoints of the derivative chromosomes,
redefining the karyotype as 46,XX,der(2)t(2;11) (p23;p14),der(3)
(:3p21->3q29:11q13->11q23:9p21w22->9pter),der(9)t(9;11)
(p21w22;q23), der(11) (2pter->2p23:3p21->3p14:11p14->
11q13:3p14->3pter) (Figures 1De1F).
Because the 5ʹ MLL signal had an unusual rearrangement,
LDI-PCR was performed to identify the MLL translocation
partner. This analysis revealed the recurrent gene fusionMLL-
MLLT3 and its reciprocal, MLLT3-MLL. The genomic break-
point on the derivative (11) chromosome was mapped to MLL
exon 11 and MLLT3 intron 5 (Figure 1G), and the reciprocal
fusion on the derivative (9) chromosome was mapped to
MLLT3 intron 5 and MLL intron 10 (Figure 1H).
Discussion
FISH analysis using locus-specific probes is a very useful
complement to conventional cytogenetic analysis when used
to screen MLL abnormalities, especially in cases in which
Figure 1 (A) Karyotype with GTG-banding shows the absence of one chromosome 3 copy, the presence of chromosome 2 and 11
derivatives, and a marker chromosome (arrows). (B) Molecular cytogenetics analysis using whole chromosome painting for chro-
mosomes 2 (yellow probe) and 9 (green probe) and partial chromosome painting for the 11 p (blue probe) and q (violet probe) arms.
Chromosome 11p material (blue) is seen on der(2), and chromosome 2 material (yellow) is seen on the p arm of der(11). Similarly, 11q
material (violet) is visible on der(3) and on the p arm of der(9). (C) FISH analysis using anMLL break-apart probe reveals 3ʹ MLL signal
(red) on the der(9) (green) and 5ʹ MLL signal (green) on the der(3). (DeF) MCB analysis of chromosomes 3, 9, and 11. In each
experiment, the chromosomal region are represented in colorful sequence and the nonidentified region are in gray; (D) MCB for
chromosome 3 showing a normal chromosome 3 copy (3), the derivative chromosome 3 (der(3)) harboring the 3p21->3p29 chro-
mosomal region and derivative chromosome 11 (der(11)) harboring 3p21->3p14 and 3p14->3pter regions; V MCB for chromosome 9
showing a normal chromosome 9 copy (9), the derivative chromosome 9 (der(9)) harboring 9p21w22->qter region and der(3)
harboring 9p21w22 region; (F) MCB for chromosome 11 showing a normal chromosome 11 copy (11), and the derivative chromo-
some 2 (der(2)) harboring 11p14 region, the der(3) harboring 11q13->11q23 and der(9) harboring 11q23 region and the der(11)
harboring the 11p14->11q13 region. (Figure Continues)
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ular, MCB of marker chromosomes can greatly refine com-
plex karyotypes by identifying breakpoints more precisely.
LDI-PCR is also an important tool for identifying which
gene fusions are involved in putative new rearrangements.
MLL-MLLT3 fusion has frequently been found in associ-
ation with AML cases (2,6,14). Some investigators have
observed that patients harboring a t(9;11) may exhibit
different epidemiologic factors, such as a higher frequency of
AML phenotype, predominance of male gender (1,15), and
diverging outcomes (16,17). The world distribution of the
t(9;11) also looks very discrepant. A multicentric study of
MLL-r observed that the great majority of patients were Eu-
ropeans, and few were Americans or Asians (251, 16, and 24patients, respectively) (1). Little is known about the t(9;11) in
childhood ALL, and even less is known about its complex
variants. In a previously reported study, our group observed
two cases of childhood ALL that presented with an MLL-
MLLT3 fusion; in one of those cases, the gene fusion was
cryptically inserted into a t(11;22) (q23;q?), and LDI studies
described the cryptic three-way MLL-MLLT3-CYP2DP1
fusion gene (18). Furthermore, a collaborative MLL recom-
binome study comprising a great number of institutions
worldwide showed that 8.5% of cases presenting MLL-
MLLT3 fusions had complex karyotypes. Moreover, the
majority of karyotypes bearing a t(9;11) did not present three-
way gene fusions, which could point to differences in
leukemic transformation mechanisms. The study’s findings
Figure 1 (Continued) (G,H) Genomic breakpoint analysis of the MLL rearrangement by Long-distance inverse PCR; analysis of the
MLL gene showing the MLL-MLLT3 fusion and the reciprocal MLLT3-MLL, respectively. Letters in black represent the MLL gene
sequence of (G) exon 11 and (H) intron 10, the letters in red represent the intron 5 MLLT3 gene sequence, and the letters in blue
represent so-called ‘‘mini direct repeats’’ (MDRs). (Color versions of these illustrations are available on the journal’s website at www.
cancergeneticsjournal.org.)
146 D.R. Ney Garcia et al.also suggest that ALL cases harboring the MLL-MLLT3
fusion are more frequent than previously reported (1). We
must consider that, generally, BCP-ALL blast cells have poor
chromosomal morphology (19,20), which could lead to un-
derestimation of the presence of the t(9;11) (p22;q23) vari-
ants by conventional cytogenetic techniques. Such technical
difficulties reinforce the importance of molecular approaches,
such as screening for MLL-r by using split-signal probes and
the complementary use of MCB with LDI-PCR to elucidate
MLL-r within complex karyotypes. In addition, an RT-PCR
screening assay for MLL-MLLT3 fusion transcripts would
provide an invaluable clinical tool with which to guide treat-
ment approaches.
In general, humanMLL-r is started by DNA damage, which
induces DNA repair via the nonhomologous end-joining DNA
repair pathway. When the damage involves more than three
DNA double-strand breaks, chromothripsis (a single event
generating massive, localized chromosomal rearrangement)
may be involved in generating complex karyotypes. The
results of recent next generation sequencing studies suggest
that large numbers of complex rearrangements may occur at
one or several chromosomal loci in a single catastrophic event
termed chromoanagenesis (21). The results of studies
involving the analysis of gene expression in AML models
suggest that the t(9;11) (p22;q23) may affect DNA repair (19).
Inappropriate DNA repair mechanisms in these cases may
result in accumulation of DNA double-strand breaks, contrib-
uting to rearrangements associated with complex karyotypes
(21). In the present case, the classical t(9;11) (p22;q23) was
cryptically relocated into a third chromosome in a balanced
three-way translocation. At the genome level, however, the
MLL-MLLT3 three-way translocation still displayed both
reciprocal fusion transcripts. This fact argues in favor of a
model in which a simple two-way t(9;11) (p22;q23) is the first
step, and it evolves into a more complex karyotype (1,2,14).
Whether the complex karyotype in our case arose from clonal
evolution or from a catastrophic event is difficult to establish,
but either mechanism (or a mechanism closely related to
these) is possible.In conclusion, although metaphase split-signal FISH
analysis is a crucial screening process for detection ofMLL-r,
other molecular cytogenetic techniques, such as MCB, can
elucidate the complexity of this karyotype. Additional studies
are needed to verify the gene fusions implicated by other
breakpoints observed in this case and their biological relation
to leukemia.
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